Therapy of corneal endothelial dysfunction with corneal endothelial cell-like cells derived from skin-derived precursors

Lin Shen,Peng Sun,Canwei Zhang,Le Yang,Liqun Du,Xinyi Wu

DOI: https://doi.org/10.1038/s41598-017-13787-1

IF: 4.6

2017-10-17

Scientific Reports

Abstract:Corneal endothelial dysfunction occurs when corneal endothelial cells (CECs) are dramatically lost and eventually results in vision loss. Corneal transplantation is the only solution at present. However, corneal transplantation requires a fresh human cornea and there is a worldwide shortage of donors. Therefore, finding new functional CECs to replace human CECs is urgent. Skin-derived precursors (SKPs) can be easily acquired and have multiple differential potential. We co-cultured human SKPs with B4G12 cells in serum-free medium and obtained abundant CEC-like cells which had similar morphology and characteristic to human CECs. CEC-like cells exerted excellent therapeutic effect when they were transplanted into rabbit and monkey corneal endothelial dysfunction models by injection method. This protocol enables efficient production of CEC-like cells from SKPs. The renewable cell source, novel derivation method and simple treatment strategy may lead to potential applications in cell replacement therapy for corneal endothelial dysfunction.

multidisciplinary sciences